PODD on Nasdaq
Insulet (United States)
Insulin delivery device company.1
Price unavailable
Last updated Oct 19, 2026.
Overview
2000Founded1
Compare with Globus Medical, West Pharmaceutical Services (United States) or MiniMed Group, Inc., or pick any stock.
- TickerPODD on Nasdaq1
- IndustrySurgical & Medical Instruments & Apparatus1
- HeadquartersBedford1
- Websitewww.insulet.com
- Incorporated inDE3
- Business address100 Nagog Park, Acton, Ma 017203
- Filer categoryLarge accelerated filer3
See how the biggest companies compare on our leaderboards
Insulet Corporation (“we” or the “Company”) is primarily engaged in the development, manufacture, and sale of its proprietary continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod platform includes: the Omnipod ® 5 Automated Insulin Delivery System (“Omnipod 5”), the Omnipod DASH ® Insulin Management System (“Omnipod DASH”), and the Omnipod Insulin Management System (“Classic Omnipod”).4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
71.6%Gross margin5
17.5%Operating margin5
9.1%Net margin5
30.7%Revenue growth, 20255
16.3%Return on equity5
$377.7MFree cash flow5
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
U.S. Omnipod brought in 71% of the revenue Insulet (United States) broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| U.S. Omnipod | $1.3B | $1.5B | $1.9B |
| International Omnipod | $410.1M | $523.4M | $754.3M |
| Drug Delivery | $36.0M | $38.9M | $34.1M |
Regions
United States brought in 72% of the revenue Insulet (United States) broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| United States | $1.3B | $1.5B | $2.0B |
| Outside the United States | $410.1M | $523.4M | $754.3M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue28¢$768.2M
- Research and development11¢$301.1M
- Selling, general and admin43¢$1.2B
- Other costs5¢$134.3M
- Income tax3¢$92.4M
- Profit9¢$247.1M
Out of $2.7B in revenue.5
Where each dollar of operating cash went, fiscal 2025
- Capital spending34¢$191.6M
- Share buybacks10¢$59.6M
- Kept or used elsewhere56¢$318.1M
Out of $569.3M of cash from operations.5
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | $2.7B | $2.1B | $1.7B |
| Cost of revenue | $768.2M | $625.9M | $537.2M |
| Gross profit | $1.9B | $1.4B | $1.2B |
| Research and development expenses | $301.1M | $219.6M | $205.0M |
| Selling, general and administrative expenses | $1.2B | $917.2M | $734.8M |
| Operating income | $473.8M | $308.9M | $220.1M |
| Interest expense, net of portion capitalized (Note 8) | -$59.4M | -$42.7M | -$36.2M |
| Interest income | $34.7M | $39.5M | $28.6M |
| Loss on extinguishment of debt | -$123.9M | $0 | $0 |
| Other income (expense), net | $14.3M | -$5.5M | $2.2M |
| Income before income taxes | $339.5M | $300.2M | $214.7M |
| Income tax (expense) benefit | -$92.4M | $118.1M | -$8.3M |
| Net income | $247.1M | $418.3M | $206.3M |
| Basic (in dollars per share) | $3.51 | $5.97 | $2.96 |
| Diluted (in dollars per share) | $3.48 | $5.78 | $2.94 |
| Basic (in shares) | 70.3M shares | 70.1M shares | 69.8M shares |
| Diluted (in shares) | 71.9M shares | 73.9M shares | 73.6M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $716.1M | $953.4M | ||
| Inventories | $452.6M | $430.4M | ||
| Prepaid expenses and other current assets | $228.3M | $142.0M | ||
| Total current assets | $1.9B | $1.9B | ||
| Property, plant and equipment, net | $819.5M | $723.1M | ||
| Other intangible assets, net | $117.1M | $98.5M | ||
| Goodwill | $51.6M | $51.5M | $51.7M | |
| Deferred tax assets | $82.4M | $141.8M | ||
| Other assets (includes $1.0 and $10.1 at fair value) | $205.8M | $181.5M | ||
| Total assets | $3.2B | $3.1B | ||
| Accounts payable | $75.0M | $19.8M | ||
| Current portion of long-term debt | $18.4M | $83.8M | ||
| Total current liabilities | $680.1M | $528.4M | ||
| Long-term debt, net | $930.8M | $1.3B | ||
| Other liabilities | $64.4M | $51.7M | ||
| Total liabilities | $1.7B | $1.9B | ||
| Preferred stock, $.001 par value, 5,000,000 authorized; none issued and outstanding | $0 | $0 | ||
| Common stock, $.001 par value, 100,000,000 authorized; 70,588,192 and 70,390,816 shares issued and outstanding, respectively, at December 31, 2025; and 70,196,031 issued and outstanding, at December 31, 2024 | $100.0K | $100.0K | ||
| Additional paid-in capital | $1.3B | $1.2B | ||
| Accumulated earnings (deficit) | $287.4M | $40.3M | ||
| Accumulated other comprehensive income (loss) | $12.5M | -$13.2M | ||
| Treasury stock, at cost; 197,374 and shares | -$60.4M | $0 | ||
| Deferred compensation | $800.0K | $0 | ||
| Total stockholders equity | $1.5B | $1.2B | $732.7M | $476.4M |
| Total liabilities and stockholders equity | $3.2B | $3.1B | ||
| Other assets, at fair value | $1.0M | $10.1M | ||
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, authorized (in shares) | 5.0M shares | 5.0M shares | ||
| Preferred stock, issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Common stock, authorized (in shares) | 100.0M shares | 100.0M shares | ||
| Common stock, issued (in shares) | 70.6M shares | 70.2M shares | ||
| Common stock, outstanding (in shares) | 70.4M shares | 70.2M shares | ||
| Treasury stock (in shares) | 197.4M shares | 0 shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $716.1M | $953.4M | ||
| Inventories | $452.6M | $430.4M | ||
| Prepaid expenses and other current assets | $228.3M | $142.0M | ||
| Total current assets | $1.9B | $1.9B | ||
| Property, plant and equipment, net | $819.5M | $723.1M | ||
| Other intangible assets, net | $117.1M | $98.5M | ||
| Goodwill | $51.6M | $51.5M | $51.7M | |
| Deferred tax assets | $82.4M | $141.8M | ||
| Other assets (includes $1.0 and $10.1 at fair value) | $205.8M | $181.5M | ||
| Total assets | $3.2B | $3.1B | ||
| Accounts payable | $75.0M | $19.8M | ||
| Current portion of long-term debt | $18.4M | $83.8M | ||
| Total current liabilities | $680.1M | $528.4M | ||
| Long-term debt, net | $930.8M | $1.3B | ||
| Other liabilities | $64.4M | $51.7M | ||
| Total liabilities | $1.7B | $1.9B | ||
| Preferred stock, $.001 par value, 5,000,000 authorized; none issued and outstanding | $0 | $0 | ||
| Common stock, $.001 par value, 100,000,000 authorized; 70,588,192 and 70,390,816 shares issued and outstanding, respectively, at December 31, 2025; and 70,196,031 issued and outstanding, at December 31, 2024 | $100.0K | $100.0K | ||
| Additional paid-in capital | $1.3B | $1.2B | ||
| Accumulated earnings (deficit) | $287.4M | $40.3M | ||
| Accumulated other comprehensive income (loss) | $12.5M | -$13.2M | ||
| Treasury stock, at cost; 197,374 and shares | -$60.4M | $0 | ||
| Deferred compensation | $800.0K | $0 | ||
| Total stockholders equity | $1.5B | $1.2B | $732.7M | $476.4M |
| Total liabilities and stockholders equity | $3.2B | $3.1B | ||
| Other assets, at fair value | $1.0M | $10.1M | ||
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, authorized (in shares) | 5.0M shares | 5.0M shares | ||
| Preferred stock, issued (in shares) | 0 shares | 0 shares | ||
| Preferred stock, outstanding (in shares) | 0 shares | 0 shares | ||
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | ||
| Common stock, authorized (in shares) | 100.0M shares | 100.0M shares | ||
| Common stock, issued (in shares) | 70.6M shares | 70.2M shares | ||
| Common stock, outstanding (in shares) | 70.4M shares | 70.2M shares | ||
| Treasury stock (in shares) | 197.4M shares | 0 shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $247.1M | $418.3M | $206.3M |
| Depreciation and amortization | $90.4M | $80.8M | $72.8M |
| Stock-based compensation expense | $62.7M | $69.3M | $48.4M |
| Deferred income taxes | $62.2M | -$136.9M | $500.0K |
| Non-cash interest expense | $6.2M | $7.3M | $6.7M |
| Loss on extinguishment of debt | $123.9M | $0 | $0 |
| Gain on derivative asset | -$12.5M | $0 | $0 |
| Provisions for credit losses | $5.4M | -$200.0K | $2.3M |
| Loss (gain) on investments | $0 | $3.9M | -$2.6M |
| Other | $7.0M | $4.9M | $2.0M |
| Inventories | -$10.6M | -$32.4M | -$53.6M |
| Prepaid expenses and other assets | -$81.7M | -$21.9M | -$42.1M |
| Accounts payable | $49.2M | $2.2M | -$11.0M |
| Net cash provided by operating activities | $569.3M | $430.2M | $145.7M |
| Capital expenditures | -$191.6M | -$124.9M | -$75.6M |
| Investments in developed software | -$19.2M | -$9.1M | -$8.5M |
| Acquisition of other intangible assets | -$8.6M | $0 | -$25.1M |
| Cash paid for investments | $0 | -$12.2M | -$7.2M |
| Other | -$3.2M | $0 | -$3.0M |
| Net cash used in investing activities | -$222.7M | -$146.2M | -$119.4M |
| Proceeds from issuance of senior unsecured notes, net of issuance costs | $440.7M | $0 | $0 |
| Proceeds from issuance of Term Loan B, net of issuance costs | $15.5M | $130.0M | $0 |
| Repayment of Term Loan B | -$20.5M | -$137.2M | -$5.0M |
| Repayment of equipment financings | -$18.2M | -$19.0M | -$19.8M |
| Repayment of Convertible Senior Notes | -$1.1B | $0 | $0 |
| Financing lease repayments | $0 | -$22.7M | $0 |
| Repayment of mortgage | -$60.9M | -$2.4M | -$2.2M |
| Proceeds from secured borrowing (Note 5) | $49.9M | $45.5M | $0 |
| Repayment of secured borrowing (Note 5) | -$62.4M | -$34.8M | $0 |
| Settlement of capped call options | $164.6M | $0 | $0 |
| Repurchase of common stock | -$59.6M | $0 | $0 |
| Proceeds from exercise of stock options | $19.0M | $8.2M | $16.3M |
| Proceeds from issuance of common stock under employee stock purchase plan | $14.9M | $11.9M | $10.6M |
| Payment of withholding taxes in connection with vesting of restricted stock units | -$25.9M | -$7.6M | -$13.2M |
| Other | $0 | $0 | -$300.0K |
| Net cash used in financing activities | -$595.3M | -$28.0M | -$13.6M |
| Effect of exchange rate changes on cash and cash equivalents | $11.5M | -$6.8M | $1.8M |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | -$237.3M | $249.2M | $14.4M |
No quarter-by-quarter statement was filed.
Leadership
Who has led Insulet (United States), and when. Pick a name to see everywhere that person has worked.
President
Chief financial officer
Chief operating officer
20052010201520202025
- Chief executive officerAshley McEvoy May 2, 2025 to now13
- Chief executive officerJames Hollingshead Jun 2, 2022 to May 2, 202514
- Chief executive officerShacey Petrovic Jan 3, 2019 to Apr 5, 202215
- PresidentAshley McEvoy May 2, 2025 to now13
- PresidentJames Hollingshead Jun 2, 2022 to May 2, 202514
- PresidentShacey Petrovic Feb 25, 2016 to Apr 5, 202216
- PresidentDaniel J. Levangie Feb 11, 2015 to Apr 5, 201617
- Chief financial officerFlavia Pease Oct 2, 2025 to now18
- Chief financial officerLauren Budden Feb 29, 2024 to Feb 29, 202419
- Chief financial officerAna Maria Chadwick Apr 25, 2024 to Oct 2, 202520
- Chief financial officerWayde D. McMillan Feb 26, 2019 to Jul 6, 202321
- Chief financial officerMichael L. Levitz May 4, 2015 to Feb 28, 201922
- Chief financial officerAllison Dorval Nov 17, 2014 to Apr 3, 201523
- Chief financial officerBrian K. Roberts Mar 9, 2009 to Apr 3, 201424
- Chief financial officerCarsten Boess May 14, 2007 to Mar 2, 200925
- Chief operating officerEric Benjamin Feb 17, 2026 to now26
- Chief operating officerCharles Alpuche Feb 28, 2019 to Jun 7, 202227
- Chief operating officerShacey Petrovic Feb 10, 2017 to Dec 10, 201828
- Chief operating officerCharles T. Liamos Jan 11, 2011 to Jan 3, 201429
- Chief operating officerLuis Malave May 14, 2007 to Mar 3, 201030
Board members and other officers (60)
- EVP and CCOMichael Panos Apr 2, 2026 to now31
- SVP, Reg, Quality & ComplianceLaetitia Cousin Apr 3, 2023 to now32
- SVP, Global OperationsPrem Singh Apr 3, 2023 to now33
- SVP, Chief HR OfficerDan Manea May 28, 2020 to now34
- SVP, Secretary and GCJohn W. Kapples Mar 22, 2019 to Apr 2, 202135
- VP, CAO and ControllerLauren Budden May 1, 2019 to now36
- SVP, R&D, New Prod Dev. & CommEric Benjamin Feb 16, 2018 to now37
- SVP and CCOBret Christensen May 31, 2017 to Mar 1, 202338
- SVP, Global ManufacturingCharles Alpuche Feb 5, 2016 to Mar 15, 202339
- SVP, Secretary and GCDavid Colleran Feb 26, 2016 to Apr 4, 201940
- SVP, Quality and RegulatoryMichael P. Spears Feb 26, 2016 to Mar 13, 202341
- SVP, Advanced TechnologyAiman Abdel-Malek Mar 30, 2016 to Apr 1, 201942
- EVP & President, Drug DeliveryDaniel J. Levangie May 2, 2016 to May 2, 201643
- CCOShacey Petrovic Feb 11, 2015 to Mar 16, 202344
- VP, Global Regulatory, CA, QATracey Haas Wielinski Feb 28, 2014 to Mar 7, 201445
- Vice President, HRKathleen Hayes Sep 30, 2014 to Sep 30, 201446
- EVP Human ResourcesBradley A. Thomas Nov 17, 2014 to Apr 2, 201847
- Vice President, InternationalCarsten Boess Mar 3, 2010 to Apr 27, 201148
- VP of Human ResourcesDavid A. Howe Jan 26, 2009 to Mar 2, 200949
- Chief Commercial OfficerPeter Devlin Aug 18, 2009 to Jun 10, 201450
- Vice President of Asian OperatJason Ng Mar 14, 2008 to Mar 2, 200951
- Chief Human Resources OfficerAndrew Suchoff Mar 31, 2008 to Mar 31, 200852
- V.P. of Business DevelopmentWilliam D. Arthur Iii. Sep 4, 2008 to Mar 2, 200953
- Vice President of ResearchJohn Garibotto May 14, 2007 to Mar 2, 200954
- Vice President ManufacturingKevin Schmid May 14, 2007 to Mar 2, 200955
- Vice President of QualityRuthann Depietro May 14, 2007 to Sep 6, 201256
- Vice President of SalesShawna Gvazdauskas May 14, 2007 to Mar 2, 200957
- Vice President of FinanceLars Boesgaard Jun 25, 2007 to Mar 2, 200958
- Vice President of CustomerStephen Bubrick Aug 10, 2007 to Aug 10, 200759
- Board memberJay Mazelsky Jul 2, 2026 to now60
- Board memberAshley McEvoy May 2, 2025 to now13
- Board memberRobert Luther Huffines Nov 3, 2025 to now61
- Board memberFlavia Pease Jan 22, 2024 to now62
- Board memberTimothy C. Stonesifer Jan 22, 2024 to now63
- Board memberElizabeth H. Weatherman Feb 7, 2022 to now64
- Board memberLuciana Borio Oct 18, 2021 to now65
- Board memberWayne A.I. Frederick Oct 20, 2020 to now66
- Board memberShacey Petrovic Jan 3, 2019 to Feb 29, 202415
- Board memberCorinne H. Lyle Jan 29, 2019 to May 24, 202367
- Board memberJames Hollingshead Aug 1, 2019 to now68
- Board memberJames Mullen Aug 11, 2017 to May 18, 201869
- Board memberMichael R. Minogue Aug 11, 2017 to now70
- Board memberJessica Hopfield Jul 29, 2015 to now71
- Board memberTimothy J. Scannell Aug 19, 2014 to now72
- Board memberW. Mark Lortz Aug 1, 2012 to Jun 5, 201373
- Board memberDaniel J. Levangie Oct 25, 2011 to Jun 13, 201474
- Board memberJoseph S. Zakrzewski May 12, 2008 to May 18, 201775
- Board memberRegina O. Sommer May 12, 2008 to May 18, 201776
- Board memberSally Crawford Oct 23, 2008 to Jun 7, 202177
- Board memberCharles T. Liamos May 14, 2007 to Apr 3, 201578
- Board memberDe Bord Alison Peyromaure May 14, 2007 to May 12, 200879
- Board memberGary Eichhorn May 14, 2007 to Apr 21, 200980
- Board memberGordon E. Nye May 14, 2007 to Feb 7, 200881
- Board memberJonathan Silverstein May 14, 2007 to May 18, 200782
- Board memberRoss A. Jaffe Md. May 14, 2007 to Feb 22, 201283
- Board memberSamuel D. Isaly May 14, 2007 to May 14, 200784
- Board memberSteven Sobieski May 14, 2007 to May 18, 201585
- General counselJohn W. Kapples Feb 11, 2022 to now86
- General counselDavid Colleran Jul 20, 2015 to Jul 20, 201587
- General counselR. Anthony Diehl May 14, 2007 to May 13, 201588
Timeline
Filings
490 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 78 major events, 292 insider forms, 30 large holders, 70 other. The latest 20:
- Oct 5, 20264 PRIMARY DOCUMENT EDGAR
- Oct 2, 20264 PRIMARY DOCUMENT EDGAR
- Oct 2, 20264 PRIMARY DOCUMENT EDGAR
- Sep 21, 20268-K EDGAR
- Sep 16, 20268-K EDGAR
- Sep 10, 20268-K EDGAR
- Aug 24, 20264 PRIMARY DOCUMENT EDGAR
- Aug 6, 2026SCHEDULE 13G/A EDGAR
- Aug 5, 202610-Q EDGAR
- Aug 5, 20268-K EDGAR
- Aug 4, 20264 PRIMARY DOCUMENT EDGAR
- Jul 7, 20264/A PRIMARY DOCUMENT EDGAR
- Jul 2, 20264 PRIMARY DOCUMENT EDGAR
- Jul 2, 20263 PRIMARY DOCUMENT EDGAR
- Jul 2, 20264 PRIMARY DOCUMENT EDGAR
- Jun 25, 20268-K EDGAR
- Jun 4, 20264 PRIMARY DOCUMENT EDGAR
- Jun 4, 20264 PRIMARY DOCUMENT EDGAR
- Jun 3, 2026144 EDGAR
- Jun 3, 20264 PRIMARY DOCUMENT EDGAR
The 490 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
65 open-market trades by officers, directors and large owners since October 2021: 10 buys and 55 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 21, 2026 | McEvoy AshleyPresident and CEO | Buy | 1,100 | $147.47 | $162.2K | Form 4 |
| Jun 3, 2026 | STONESIFER TIMOTHY C.Director | Buy | 2,790 | $143.51 | $400.4K | Form 4 |
| Jun 3, 2026 | BORIO LUCIANADirector | Sale | 418 | $143.27 | $59.9K | Form 4 |
| Jun 3, 2026 | WEATHERMAN ELIZABETH HDirector | Buy | 3,450 | $144.20 | $497.5K | Form 4 |
| Feb 25, 2026 | MINOGUE MICHAEL RDirector | Buy | 2,030 | $246.23 | $499.8K | Form 4 |
| Feb 20, 2026 | McEvoy AshleyPresident and CEO | Buy | 4,300 | $239.35 | $1.0M | Form 4 |
| Dec 15, 2025 | Frederick Wayne A.I.Director | Sale | 1,851 | $293.09 | $542.5K | Form 4 |
| Dec 5, 2025 | STONESIFER TIMOTHY C.Director | Buy | 962 | $311.73 | $299.9K | Form 4 |
| Sep 8, 2025 | Singh PremSVP, Global Operations | Sale | 687 | $347.49 | $238.7K | Form 4 |
| Sep 8, 2025 | Cousin LaetitiaSVP, Reg, Quality & Compliance | Sale | 797 | $348.81 | $278.0K | Form 4 |
| Aug 21, 2025 | Benjamin EricEVP and COO | Sale | 4,263 | $332.23 | $1.4M | Form 4 |
| Aug 7, 2025 | Singh PremSVP, Global Operations | Sale | 1,343 | $320.00 | $429.8K | Form 4 |
| Jun 13, 2025 | Singh PremSVP, Global Operations | Sale | 2,327 | $300.05 | $698.2K | Form 4 |
| Jun 13, 2025 | Manea DanSVP, Chief HR Officer | Sale | 1,300 | $300.05 | $390.1K | Form 4 |
| Jun 9, 2025 | BORIO LUCIANADirector | Sale | 481 | $305.73 | $147.1K | Form 4 |
| May 14, 2025 | Kapples John W.SVP and General Counsel | Sale | 5,278 | $318.47 | $1.7M | Form 4 |
| May 13, 2025 | Hopfield JessicaDirector | Sale | 5,235 | $317.54 | $1.7M | Form 4 |
| May 13, 2025 | Benjamin EricEVP and COO | Sale | 3,001 | $320.00 | $960.3K | Form 4 |
| Mar 25, 2025 | Frederick Wayne A.I.Director | Sale | 1,825 | $275.00 | $501.9K | Form 4 |
| Jan 21, 2025 | Benjamin EricEVP and COO | Sale | 12,394 | $280.00 | $3.5M | Form 4 |
All 65 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- FMR LLCSCHEDULE 13G/A, 8 filings Feb 9, 2022 to Aug 6, 202689
- Capital Research Global InvestorsSCHEDULE 13G/A, 7 filings Feb 11, 2022 to May 14, 202690
- VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 30, 202691
- VANGUARD GROUP INCSCHEDULE 13G/A, 6 filings Feb 10, 2022 to Mar 27, 202692
- Capital World InvestorsSC 13G/A, 3 filings Feb 11, 2022 to Feb 9, 202493
- Wellington Management CompanySC 13G/A, 2 filings Feb 6, 2023 to Feb 8, 202494
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 6,690,192 | $1.0B | 0.0% | +314,249 |
| Vanguard Capital Management LLC | 4,525,333 | $689.0M | 0.0% | −53,941 |
| State Street Corp | 3,197,555 | $486.8M | 0.0% | +155,101 |
| Vanguard Portfolio Management LLC | 3,075,932 | $468.3M | 0.0% | −374,055 |
| Aqr Capital Management LLC | 2,455,135 | $373.8M | 0.1% | +856,411 |
| Baillie Gifford & Co | 2,042,313 | $310.9M | 0.3% | +12,821 |
| Geode Capital Management, LLC | 2,003,861 | $304.0M | 0.0% | −21,837 |
| Two Sigma Investments, LP | 1,903,734 | $289.8M | 0.2% | +1,141,385 |
| Invesco Ltd. | 1,694,651 | $258.0M | 0.0% | +598,114 |
| Morgan Stanley | 1,479,050 | $225.2M | 0.0% | +333,119 |
| Arrowstreet Capital, Limited Partnership | 1,471,069 | $224.0M | 0.1% | +241,141 |
| Clearbridge Investments, LLC | 1,319,381 | $200.9M | 0.2% | −1,645 |
| Soleus Capital Management, L.P. | 1,049,000 | $159.7M | 5.5% | +486,500 |
| Norges Bank | 1,047,986 | $159.6M | 0.0% | New |
| Jupiter Asset Management Ltd | 1,026,691 | $156.3M | 0.8% | +316,789 |
| Fmr LLC | 964,297 | $146.8M | 0.0% | −3,010,415 |
| Millennium Management LLC | 865,387 | $131.8M | 0.1% | +566,795 |
| FIL Ltd | 840,026 | $127.9M | 0.1% | −171,979 |
| Goldman Sachs Group Inc | 818,265 | $124.6M | 0.0% | −45,651 |
| Citadel Advisors LLC | 796,746 | $121.3M | 0.1% | +643,307 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 773,361 | $117.7M | 0.0% | −21,986 |
| Federated Hermes, Inc. | 702,194 | $106.9M | 0.2% | −11,698 |
| Vestal Point Capital, LP | 670,000 | $102.0M | 2.4% | +619,399 |
| Qube Research & Technologies Ltd | 663,968 | $101.1M | 0.1% | +22,292 |
| Northern Trust Corp | 649,908 | $98.9M | 0.0% | −43,909 |
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
11 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Sep 18, 2026 | Gilbert Ray Cisneros, Jr.Democratic, House | Partial sale | $1,001 - $15,000 | +2.6% | Report |
| Aug 18, 2026 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | −6.8% | Report |
| May 7, 2026 | Tina SmithDemocratic, Senate | Sale | $100,001 - $250,000 | +19.0% | Report |
| Apr 29, 2026 | Tina SmithDemocratic, Senate | Partial sale | $100,001 - $250,000 | +21.7% | Report |
| Apr 4, 2024 | Tina SmithDemocratic, Senate | Partial sale | $50,001 - $100,000 | +65.4% | Report |
| Jan 4, 2024 | Markwayne Mullin, Senate | Sale | $1,001 - $15,000 | +95.7% | Report |
| Dec 22, 2023 | Markwayne Mullin, Senate | Partial sale | $1,001 - $15,000 | +98.8% | Report |
| Jul 12, 2023 | Daniel S. GoldmanDemocratic, House | Sale | $1,001 - $15,000 | +124.4% | Report |
| Apr 10, 2023 | Daniel S. GoldmanDemocratic, House | Buy | $1,001 - $15,000 | −144.4% | Report |
| Jan 3, 2023 | Markwayne Mullin, Senate | Buy | $1,001 - $15,000 | −154.2% | Report |
| Mar 17, 2020 | Tina SmithDemocratic, Senate | Partial sale | $250,001 - $500,000 | +198.6% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
Links
- Websitewww.insulet.com1
- LinkedInwww.linkedin.com/company/insulet-corporation1
- WikidataQ104480795
- SEC EDGARCIK 1145197
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16SEC EDGARShacey Petrovic, President
- 17SEC EDGARDaniel J. Levangie, President
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30SEC EDGARLuis Malave, Chief operating officer
- 31SEC EDGARMichael Panos, EVP and CCO
- 32
- 33SEC EDGARPrem Singh, SVP, Global Operations
- 34SEC EDGARDan Manea, SVP, Chief HR Officer
- 35
- 36
- 37
- 38SEC EDGARBret Christensen, SVP and CCO
- 39
- 40
- 41
- 42
- 43
- 44SEC EDGARShacey Petrovic, CCO
- 45
- 46SEC EDGARKathleen Hayes, Vice President, HR
- 47
- 48
- 49SEC EDGARDavid A. Howe, VP of Human Resources
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60SEC EDGARJay Mazelsky, Board member
- 61SEC EDGARRobert Luther Huffines, Board member
- 62SEC EDGARFlavia Pease, Board member
- 63SEC EDGARTimothy C. Stonesifer, Board member
- 64
- 65SEC EDGARLuciana Borio, Board member
- 66SEC EDGARWayne A.I. Frederick, Board member
- 67SEC EDGARCorinne H. Lyle, Board member
- 68SEC EDGARJames Hollingshead, Board member
- 69SEC EDGARJames Mullen, Board member
- 70SEC EDGARMichael R. Minogue, Board member
- 71SEC EDGARJessica Hopfield, Board member
- 72SEC EDGARTimothy J. Scannell, Board member
- 73SEC EDGARW. Mark Lortz, Board member
- 74SEC EDGARDaniel J. Levangie, Board member
- 75SEC EDGARJoseph S. Zakrzewski, Board member
- 76SEC EDGARRegina O. Sommer, Board member
- 77SEC EDGARSally Crawford, Board member
- 78SEC EDGARCharles T. Liamos, Board member
- 79
- 80SEC EDGARGary Eichhorn, Board member
- 81SEC EDGARGordon E. Nye, Board member
- 82SEC EDGARJonathan Silverstein, Board member
- 83SEC EDGARRoss A. Jaffe Md., Board member
- 84SEC EDGARSamuel D. Isaly, Board member
- 85SEC EDGARSteven Sobieski, Board member
- 86SEC EDGARJohn W. Kapples, General counsel
- 87SEC EDGARDavid Colleran, General counsel
- 88SEC EDGARR. Anthony Diehl, General counsel
- 89
- 90
- 91
- 92
- 93
- 94